Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas.

Champ CE, Siglin J, Mishra MV, Shen X, Werner-Wasik M, Andrews DW, Mayekar SU, Liu H, Shi W.

Radiat Oncol. 2012 Dec 21;7:220. doi: 10.1186/1748-717X-7-220.

2.
3.

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma.

Navarria P, Reggiori G, Pessina F, Ascolese AM, Tomatis S, Mancosu P, Lobefalo F, Clerici E, Lopci E, Bizzi A, Grimaldi M, Chiti A, Simonelli M, Santoro A, Bello L, Scorsetti M.

Radiother Oncol. 2014 Sep;112(3):425-9. doi: 10.1016/j.radonc.2014.09.004. Epub 2014 Oct 9.

PMID:
25308182
4.

Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies.

Tsien C, Gomez-Hassan D, Ten Haken RK, Tatro D, Junck L, Chenevert TL, Lawrence T.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):328-32.

PMID:
15890571
5.

Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.

Guarnaschelli JN, Vagal AS, McKenzie JT, McPherson CM, Warnick RE, Batra V, Breneman JC, Lamba MA.

Pract Radiat Oncol. 2014 Sep-Oct;4(5):e195-201. doi: 10.1016/j.prro.2013.11.003. Epub 2014 Jan 8.

PMID:
25194105
6.

Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.

Stall B, Zach L, Ning H, Ondos J, Arora B, Shankavaram U, Miller RW, Citrin D, Camphausen K.

Radiat Oncol. 2010 Jan 28;5:5. doi: 10.1186/1748-717X-5-5.

7.

(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.

Zhao F, Li M, Wang Z, Fu Z, Cui Y, Chen Z, Yu J.

PLoS One. 2015 Mar 4;10(3):e0118769. doi: 10.1371/journal.pone.0118769. eCollection 2015.

8.

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.

Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42. doi: 10.1016/j.ijrobp.2012.05.031. Epub 2012 Jul 3.

PMID:
22765876
9.

Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.

Munck Af Rosenschold P, Costa J, Engelholm SA, Lundemann MJ, Law I, Ohlhues L, Engelholm S.

Neuro Oncol. 2015 May;17(5):757-63. doi: 10.1093/neuonc/nou316. Epub 2014 Dec 23.

10.

Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.

Anand AK, Kumar P, Patir R, Vaishya S, Bansal AK, Chaudhoory AR, Punnakal AU, Malhotra H, Munjal RK.

J Cancer Res Ther. 2014 Jan-Mar;10(1):97-102. doi: 10.4103/0973-1482.131403.

11.

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Berger MS, Deliganis AV, Dobbins J, Keles GE.

Cancer. 1994 Sep 15;74(6):1784-91.

12.

Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.

Pech M, Mohnike K, Wieners G, Bialek E, Dudeck O, Seidensticker M, Peters N, Wust P, Gademann G, Ricke J.

Strahlenther Onkol. 2008 May;184(5):256-61. doi: 10.1007/s00066-008-1849-8.

PMID:
18427756
13.

Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.

Castadot P, Geets X, Lee JA, Christian N, Grégoire V.

Radiother Oncol. 2010 May;95(2):209-17. doi: 10.1016/j.radonc.2010.03.007. Epub 2010 Apr 10.

PMID:
20385413
14.

The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?

Paulino AC.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):757-61.

PMID:
11172959
15.

Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?

Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M.

Radiother Oncol. 2004 Nov;73(2):141-8.

PMID:
15542160
16.

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.

Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.

Cancer. 2004 Aug 15;101(4):713-20.

17.

Change in pattern of relapse after antiangiogenic therapy in high-grade glioma.

Narayana A, Kunnakkat SD, Medabalmi P, Golfinos J, Parker E, Knopp E, Zagzag D, Eagan P, Gruber D, Gruber ML.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):77-82. doi: 10.1016/j.ijrobp.2010.10.038. Epub 2010 Dec 14.

PMID:
21163583
18.

Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.

Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):585-90. doi: 10.1016/j.ijrobp.2013.02.024. Epub 2013 Apr 26.

PMID:
23628134
19.

T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.

Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD.

Neurosurgery. 2010 Mar;66(3):486-91; discussion 491-2. doi: 10.1227/01.NEU.0000360391.35749.A5.

PMID:
20173543
20.

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy.

Quon H, Brunet B, Alexander A, Murtha A, Abdulkarim B, Fulton D, Smerdely M, Johnson M, Urtasun R, Patel S, Ghosh S, Roa W.

Anticancer Res. 2011 Oct;31(10):3559-65.

PMID:
21965778

Supplemental Content

Support Center